Journal
DRUG DESIGN DEVELOPMENT AND THERAPY
Volume 13, Issue -, Pages 2633-2641Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S211845
Keywords
[6]-gingerol; ondansetron; kaolin; pica; gut microbiota; cisplatin
Categories
Funding
- National Natural Science Foundation of China [81673779, 81803912]
- Scientific Research Project of the Administration of Traditional Chinese Medicine of Guangdong Province [20182079]
- Characteristic Innovation Project (Natural Science) of the Education Department of Guangdong Province
- Innovation Strong School Project of Guangdong Pharmaceutical University [2017KTSCX102]
- Science and Technology Project of Yue-Xiu District of Guangzhou [2018-WS-011]
Ask authors/readers for more resources
Purpose: [6]-gingerol is one of the main components of ginger with many biological activities. In this study, the effects of ondansetron and [6]-gingerol on pica and gut microbiota in rats injected with cisplatin were evaluated. Materials and methods: Rat model of cisplatin-induced pica was established, and the effects of ondansetron and [6]-gingerol on the gut microbiota were further studied by 16S rDNA gene analysis. Results: The results showed that the total intake of kaolin of the rats injected with cisplatin was significantly increased, and treatment of ondansetron and [6]-gingerol in advance could significantly ameliorate the pica induced by cisplatin. The body weight of the rats injected with cisplatin was decreased compared with the control group. The 16S rDNA gene analysis has shown that ondansetron, [6]-gingerol and cisplatin could increase the relative abundance of Bacteroidetes and decrease Firmicutes on phylum level. Conclusion: [6]-gingerol was as effective as ondansetron in the treatment of pica induced by cisplatin in rats, and it seemed that [6]-gingerol had the potential to ameliorate the alteration of gut microbiome, but it needs further study.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available